her 2 negative
Aberrant miRNAs expressed in HER-2 negative breast cancers patient
16
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer
6
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients
9
A different immunologic profile characterizes patients with HER 2 overexpressing and HER 2 negative locally advanced breast cancer: implications for immune based therapies
13
Original Article Expression of sarcosine metabolism-related proteins in estrogen receptor negative breast cancer according to the androgen receptor and HER-2 status
11
A Meta Analysis of Lymphatic Vessel Invasion Correlated with Pathologic Factors in Invasive Breast Cancer
7
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer
12
Trastuzumab anti tumor efficacy in patient derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
11
Clinical Initial Response of Neoadjuvant Chemotheraphy in Triple Negative, HER-2, and Luminal Types of Breast Cancer in Denpasar (A Preliminary Study)
5
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
10
<em>FcγRIIA</em> and <em>IIIA </em>polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
12
Interactive Visualization for Linguistic Structure
6
The Ethnic Identity Crisis and Acculturation in Shakir's "Let's Dance"
6
HER 2 NEU and KI67 expression as immunolocalisation in colorectal carcinoma
143
Critical Assessment of Love between Hamlet and Ophelia with Reference to Ophelia’s Situation and Hamlet’s State of Mind
16
Retaliation and the Reasonable Person
51
Intracellular signaling pathways of ErbB2/HER 2 and family members
5
Baby Booey's gift
99
Vol 3, No 12 (2015)
5
Negative genic switch of HER 2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2 positive breast cancer
5